🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To perform an observational analysis to emulate a target trial (i.e., a hyp...
Status
Active Not Recruiting
Location
Brigham and Women's Hospital
Start Date
2021-08-01
Trial ID
NCT05220917
Treatments Being Tested
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...
Status
Completed
Location
Axis Clinicals Latina, S.A. de C.V.
Start Date
2025-02-17
Trial ID
NCT07633015
Treatments Being Tested
This trial is to establish bioequivalence of the fixed dose combination (FD...
Status
Completed
Location
Instituto de Ciências Farmacêuticas de Estudos e Pesquisas - ICF
Start Date
2021-07-23
Trial ID
NCT05083949
Treatments Being Tested
This is a Randomized, open-label, single oral dosing, two-sequence, and two...
Status
Completed
Location
Chung-Ang University Gwangmyeong Hospital
Start Date
2024-04-04
Trial ID
NCT06483243
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...
Status
Completed
Location
Axis Clinicals Latina, S.A. de C.V.
Start Date
2025-09-10
Trial ID
NCT07633054
Treatments Being Tested
Comparative randomized, single dose, two-way crossover open-label study to ...
Status
Completed
Location
Genuine Research Center GRC
Start Date
2019-03-26
Trial ID
NCT05132023
Treatments Being Tested
The primary objective of this trial is to establish the bioequivalence of t...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2018-08-27
Trial ID
NCT03629054
This is a randomized, open-label, single dose, crossover, phase Ⅰ trial to ...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2023-11-21
Trial ID
NCT06204107
To establish the bioequivalence of one fixed dose combination (FDC) tablet ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2017-08-31
Trial ID
NCT03259490
Treatments Being Tested
Prospective, longitudinal, single-dose, randomized, open-label, crossover 2...
Status
Completed
Location
Axis Clinicals Latina, S.A. de C.V.
Start Date
2025-02-10
Trial ID
NCT07633028
Treatments Being Tested